SXC Health Solutions to raise $176.6 million from sale of common shares

SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: SXCI, TSX: SXC) announced today the pricing of its previously announced public offering of common shares. Under the offering, SXC will sell 4,500,000 common shares at a price to the public of $41.50 per share. The offering was increased from the previously announced offering size of 3,500,000 common shares. In connection with the offering, SXC has granted the underwriters a 30-day option to purchase up to an additional 675,000 of its common shares at the public offering price to cover over-allotments, if any. The offering is expected to close on September 23, 2009, subject to customary closing conditions.

SXC expects to receive net proceeds from the offering of approximately $176.6 million (or approximately $203.3 million if the underwriters exercise their over-allotment option in full), after deducting the underwriting discounts and commissions and estimated offering expenses. SXC intends to use the net proceeds from the offering for general corporate purposes, which may include financing potential acquisitions and strategic transactions, funding capital expenditures and providing working capital to enhance capital and maintain financial flexibility.

The offering is being conducted as a public offering pursuant to an effective shelf registration statement under the Securities Act of 1933 and, in Canada, pursuant to a prospectus supplement to the Company's base shelf prospectus dated September 14, 2009 (the "Canadian Prospectus"). J.P. Morgan Securities Inc. is acting as the sole book-running manager for the offering. The lead managers of the offering are Dougherty Company LLC, SunTrust Robinson Humphrey, Inc. and Versant Partners Inc., and the co-managers are Oppenheimer Co. Inc. and Paradigm Capital U.S. Inc.